CJ Bioscience, Inc. (KOSDAQ:311690)
3,550.00
+50.00 (1.43%)
At close: Nov 13, 2026
| Market Cap | 46.38B -62.2% |
| Revenue (ttm) | 3.68B +8.7% |
| Net Income | -22.33B |
| EPS | -1,708.88 |
| Shares Out | 13.07M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,856 |
| Open | 3,490.00 |
| Previous Close | 3,500.00 |
| Day's Range | 3,310.00 - 3,590.00 |
| 52-Week Range | 3,060.00 - 10,200.00 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |